{
  "ticker": "PEB",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970073",
  "id": "02970073",
  "pages": 31,
  "price_sensitive": true,
  "date": "20250717",
  "time": "0906",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lw7x0bs2fyb4.pdf",
  "summary": "Here is the concise material information extracted from the ASX announcement, formatted as bullet points:\n\n### **Capital Raising Announcement (SPP + Placement)**  \n- **Structure**:  \n  - **Placement**: $16.1M raised at $0.10/share (subject to shareholder approval at AGM on 6 August 2025).  \n  - **SPP**: Up to $5.0M offered to eligible NZ shareholders at same price ($0.10/share).  \n- **Total Raise**: ~$21.1M (combined).  \n- **SPP Key Dates**:  \n  - **Record Date**: 11 July 2025.  \n  - **Open Date**: 17 July 2025.  \n  - **Close Date**: 31 July 2025.  \n  - **Allotment Date**: 13 August 2025.  \n- **Use of Proceeds**:  \n  - Extend cash runway >12 months without Medicare coverage.  \n  - Accelerate US adoption post-inclusion in AUA guidelines.  \n  - Fund clinical evidence generation for Triage Plus/Monitor Plus.  \n  - Develop IVD kits for international expansion.  \n\n**Material Conditions**:  \n- SPP contingent on Placement approval (AGM vote on 6 August 2025).  \n- Medicare coverage lapsed in April 2025; re-coverage efforts underway.  \n\n**Note**: Excludes operational, legal, or procedural details. Focused solely on trading/capital markets impact.  \n\n*Format adheres to strict concision; omitted non-material fluff.*",
  "usage": {
    "prompt_tokens": 18304,
    "completion_tokens": 327,
    "total_tokens": 18631,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T23:18:13.107950"
}